Brooklyn ImmunoTherapeutics Stock Rises After Novellus Therapeutics Buyout Deal
Brooklyn ImmunoTherapeutics LLC (NYSE:BTX) has executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered mesenchymal stem…
54 Biggest Movers From Yesterday
Gainers
Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.
52 Biggest Movers From Yesterday
Gainers
Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive immuno-oncology RNA therapy for the treatment of multiple cancers.
Brooklyn ImmunoTherapeutics Says Strengthens Investment In Licensed mRNA Technology Platform With $20M
Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing
Brooklyn ImmunoTherapeutics LLC (NYSE:BTX) ("Brooklyn"), a biopharmaceutical company currently
58 Biggest Movers From Yesterday
Gainers
Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday.
74 Biggest Movers From Friday
Gainers
MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter.
Publication In Breast Cancer Research Indicate Brooklyn ImmunoTherapeutics’ IRX-2 May Hold Promise In Early-Stage Breast Cancer
Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) has announced a publication in Breast Cancer Research, which demonstrates how multiplex immunofluorescence (mIF) may be used…